Guangzhou Gloria Biosciences Co., Ltd., commonly referred to as Gloria Biosciences, is a leading player in the biotechnology industry, headquartered in Guangzhou, China. Established in 2009, the company has made significant strides in the development of innovative biopharmaceuticals and diagnostic products, focusing on areas such as molecular diagnostics and therapeutic solutions. With a commitment to quality and innovation, Gloria Biosciences offers a range of unique products, including advanced reagents and diagnostic kits that cater to both clinical and research applications. The company has positioned itself as a trusted partner in the global market, achieving notable milestones in research and development. Its dedication to excellence has earned it recognition within the industry, solidifying its reputation as a key contributor to the advancement of biosciences.
How does Guangzhou Gloria Biosciences Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Guangzhou Gloria Biosciences Co., Ltd.'s score of 0 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Guangzhou Gloria Biosciences Co., Ltd., headquartered in China (CN), currently does not report any carbon emissions data, as indicated by the absence of specific figures. Consequently, there are no recorded emissions totals for Scope 1, Scope 2, or Scope 3. Additionally, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to reducing carbon emissions at this time. In the context of the biotechnology industry, many companies are increasingly focusing on sustainability and climate action. However, without specific data or commitments from Guangzhou Gloria Biosciences, it is unclear how they align with these industry trends. As the company progresses, it may consider adopting industry-standard climate initiatives to enhance its environmental responsibility and transparency.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Guangzhou Gloria Biosciences Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.